NEW YORK (Reuters Health) – A single 6-mL intra-articular injection of hylan G-F 20 (Synvisc-One, Genzyme Biosurgery) safely reduces knee osteoarthritis pain for 26 weeks, results of a…
NEW YORK (Reuters Health) – Pregnant women with type 1 diabetes had fewer severe hypoglycemic episodes when they started a preprandial insulin analog regimen before conception rather than…
NEW YORK (Reuters Health) – In elderly heart failure patients with ejection fractions of 35% or less, implantable cardioverter defibrillators (ICD) can significantly improve long-term survival, according to…
NEW YORK (Reuters Health) – In patients with asymptomatic carotid stenosis (ACS), microemboli and cardiovascular events can be markedly reduced by aggressive medical therapy, Canadian research shows. This…
NEW YORK (Reuters Health) – In diabetic patients, sirolimus-eluting stents reduce the risk for coronary artery restenosis compared with paclitaxel-eluting stents, a meta-analysis shows. Because the relative efficacy…
NEW YORK (Reuters Health) – Treatment of depression in low-income minorities with poorly controlled diabetes improved HbA1c and systolic blood pressure, investigators report in the December issue of…
NEW YORK (Reuters Health) – An investigational drug called motavizumab may offer better protection against respiratory syncytial virus (RSV) than palivizumab in high risk children, according to a…
NEW YORK (Reuters Health) – As the number of prescribed antithrombotic drugs after a first myocardial infarction increases, so does the risk of hospitalization for bleeding, according to…
NEW YORK (Reuters Health) – In children with attention deficit hyperactivity disorder (ADHD), adding divalproex to stimulant therapy can improve refractory aggression, a small study suggests. “Stimulant medications…
NEW YORK (Reuters Health) – Breast cancer recurrence rates are lower with aromatase inhibitors than with tamoxifen, according to meta-analyses published online by the Journal of Clinical Oncology.…